These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35341324)

  • 21. Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events.
    Ou J; Lan W; Wu X; Zhao T; Duan B; Yang P; Ren Y; Quan L; Zhao W; Seto D; Chodosh J; Luo Z; Wu J; Zhang Q
    Signal Transduct Target Ther; 2022 Apr; 7(1):138. PubMed ID: 35474215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher viral load and infectivity increase risk of aerosol transmission for Delta and Omicron variants of SARS-CoV-2.
    Riediker M; Briceno-Ayala L; Ichihara G; Albani D; Poffet D; Tsai DH; Iff S; Monn C
    Swiss Med Wkly; 2022 Jan; 152():w30133. PubMed ID: 35019196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA viral loads of SARS-CoV-2 Alpha and Delta variants in nasopharyngeal specimens at diagnosis stratified by age, clinical presentation and vaccination status.
    Costa R; Olea B; Bracho MA; Albert E; de Michelena P; Martínez-Costa C; González-Candelas F; Navarro D
    J Infect; 2022 Apr; 84(4):579-613. PubMed ID: 34953901
    [No Abstract]   [Full Text] [Related]  

  • 25. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells.
    Zhao H; Lu L; Peng Z; Chen LL; Meng X; Zhang C; Ip JD; Chan WM; Chu AW; Chan KH; Jin DY; Chen H; Yuen KY; To KK
    Emerg Microbes Infect; 2022 Dec; 11(1):277-283. PubMed ID: 34951565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection.
    Ra SH; Lim JS; Kim GU; Kim MJ; Jung J; Kim SH
    Thorax; 2021 Jan; 76(1):61-63. PubMed ID: 32963115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of SARS-CoV-2 Viral Loads in the Nasal Mucosa of Patients Infected With BA.1, BA.2, or BA.5 Omicron Lineages.
    Tozer K; Sjaarda CP; Moslinger E; Wong H; Mubareka S; Maguire F; Fattouh R; Brabant-Kirwan D; Kozak R; Sheth PM
    Open Forum Infect Dis; 2022 Dec; 9(12):ofac564. PubMed ID: 36483184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
    Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
    mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative instantaneous reproduction number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark.
    Ito K; Piantham C; Nishiura H
    J Med Virol; 2022 May; 94(5):2265-2268. PubMed ID: 34967453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 variants of concern Alpha and Delta show increased viral load in saliva.
    King KL; Wilson S; Napolitano JM; Sell KJ; Rennert L; Parkinson CL; Dean D
    PLoS One; 2022; 17(5):e0267750. PubMed ID: 35536777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021-February 2022.
    Sofonea MT; Roquebert B; Foulongne V; Morquin D; Verdurme L; Trombert-Paolantoni S; Roussel M; Bonetti JC; Zerah J; Haim-Boukobza S; Alizon S
    Emerg Infect Dis; 2022 Jul; 28(7):1355-1365. PubMed ID: 35642476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load.
    Migueres M; Dimeglio C; Trémeaux P; Raymond S; Lhomme S; Da Silva I; Oliveira Mendes K; Abravanel F; Félicé MP; Mansuy JM; Izopet J
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twin combination of Omicron and Delta variants triggering a tsunami wave of ever high surges in COVID-19 cases: A challenging global threat with a special focus on the Indian subcontinent.
    Mohapatra RK; Tiwari R; Sarangi AK; Sharma SK; Khandia R; Saikumar G; Dhama K
    J Med Virol; 2022 May; 94(5):1761-1765. PubMed ID: 35014038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.
    Abdelnabi R; Foo CS; Zhang X; Lemmens V; Maes P; Slechten B; Raymenants J; André E; Weynand B; Dallmeier K; Neyts J
    Antiviral Res; 2022 Feb; 198():105253. PubMed ID: 35066015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.
    Liu X; Chen M; Zhou Z; Chen D; Mo J; Liu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):344-351. PubMed ID: 35545327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.
    Alkhatib M; Salpini R; Carioti L; Ambrosio FA; D'Anna S; Duca L; Costa G; Bellocchi MC; Piermatteo L; Artese A; Santoro MM; Alcaro S; Svicher V; Ceccherini-Silberstein F
    Microbiol Spectr; 2022 Apr; 10(2):e0273221. PubMed ID: 35352942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape.
    Rochman ND; Faure G; Wolf YI; Freddolino PL; Zhang F; Koonin EV
    mBio; 2022 Apr; 13(2):e0013522. PubMed ID: 35289643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative SARS-CoV-2 Viral-Load Curves in Paired Saliva Samples and Nasal Swabs Inform Appropriate Respiratory Sampling Site and Analytical Test Sensitivity Required for Earliest Viral Detection.
    Savela ES; Viloria Winnett A; Romano AE; Porter MK; Shelby N; Akana R; Ji J; Cooper MM; Schlenker NW; Reyes JA; Carter AM; Barlow JT; Tognazzini C; Feaster M; Goh YY; Ismagilov RF
    J Clin Microbiol; 2022 Feb; 60(2):e0178521. PubMed ID: 34911366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer:RNA ratio for Delta and Epsilon vs. Alpha variants.
    Despres HW; Mills MG; Shirley DJ; Schmidt MM; Huang ML; Roychoudhury P; Jerome KR; Greninger AL; Bruce EA
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35058348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.